Sun Pharmaceutical Industries Ltd Rallies 3.06% and Approaches 100 DMA Resistance — A Key Technical Test Ahead
The Sensex advanced 2.25% on 05 Nov 2026, yet Sun Pharmaceutical Industries Ltd outpaced the benchmark with a 3.06% gain, touching an intraday high of Rs 1,833.45. This 0.81-percentage-point outperformance over the Sensex and a 2.3-percentage-point lead over its sector signals a stock-specific momentum shift rather than a mere market tailwind.
The report was published on 08 de novembro de 2026 às 06:40 by MarketsMojo and is part of the World news coverage.
What other outlets are saying
- MarketsMojo: Axis Bank Ltd. Rallies 3.16% and Approaches 200 DMA Resistance — A Key Technical Test Ahead
- https://www.siam.in/: Sun Pharmaceutical (SUNPHARMA.NS) Extends Gains, Trades at ₹1862.2 as Pharma Major Tests Resistance Zone - Runaway Gap
Quick answers
Who reported this story?
It was first reported by MarketsMojo on 08 de novembro de 2026 às 06:40.
What is the category?
It is filed under World news on Rio Warzone News.
